FUGAZZA , Giuseppina

Last name: FUGAZZA

First name: Giuseppina

Email: giusi.fugazza@unige.it

Institution: UNIGE

Links

2010 (v1)

Publication

Metadata-only

P38 MAPK and JNK antagonistically control senescence and cytoplasmic p16ink4a expression in doxorubicin-treated endothelial progenitor cells

Spallarossa, Paolo Altieri, Paola Barisione, Chiara

Patients treated with low-dose anthracyclines often show late onset cardiotoxicity. Recent studies suggest that this form of cardiotoxicity is the result of a progenitor cell disease. In this study we demonstrate that Cord Blood Endothelial Progenitor Cells (EPCs) exposed to low, sub-apoptotic doses of doxorubicin show a senescence phenotype...

Uploaded on: April 14, 2023
2015 (v1)

Publication

Metadata-only

Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes

Minetto, Paola Guolo, Fabio Clavio, Marino

No description

Uploaded on: March 27, 2023
2010 (v1)

Publication

Metadata-only

A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib

Cea, Michele Cirmena, Gabriella Garuti, Anna

No description

Uploaded on: April 14, 2023
2016 (v1)

Publication

Metadata-only

High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients

Guolo, Fabio Minetto, Paola Clavio, Marino

About 105 consecutive acute myeloid leukemia (AML) patients treated with the same induction-consolidation program between 2004 and 2013 were retrospectively analyzed. Median age was 47 years. The first induction course included fludarabine (Flu) and high-dose cytarabine (Ara-C) plus idarubicin (Ida), with or without gemtuzumab-ozogamicin (GO) 3...

Uploaded on: April 14, 2023
2018 (v1)

Publication

Metadata-only

Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

MINETTO, PAOLA GUOLO, FABIO Clavio, Marino

No description

Uploaded on: April 14, 2023

FUGAZZA , Giuseppina

Recent uploads